Investor Relations
![](/dist/images/default-page-header.png)
Investor Relations
We welcome you to explore our Investor Relations portal, where you can get to know our goals and strategies to support your investment decision and increase long-term shareholder value.
Current Financials
Second Quarter 2024 Results
Balchem reported second quarter net sales of $234.1 million, quarterly net earnings of $32.1 million, adjusted EBITDA(a) of $62.3 million, and free cash flow(a) of $38.4 million.
Ted Harris, Chairman, President and CEO of Balchem said, “We delivered solid second quarter financials with record earnings from operations and adjusted EBITDA. I am particularly pleased with the excellent performance in our Human Nutrition and Health and Specialty Products segments, both delivering strong sales and earnings growth.”
(a) See “Non-GAAP Financial Information” for a reconciliation of GAAP and non-GAAP financial measures.
![](https://stg.balchem.matchbox.host/wp-content/uploads/2023/04/Financial-Analysis-scaled.jpeg)